These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7400355)

  • 21. Abnormal mineral composition of osteogenesis imperfecta bone as determined by electron probe X-ray microanalysis on conventional and cryosections.
    Sarathchandra P; Kayser MV; Ali SY
    Calcif Tissue Int; 1999 Jul; 65(1):11-5. PubMed ID: 10369727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Osteogenesis imperfecta: contribution to pathobiochemistry].
    Pontz BF; Müller PK
    Padiatr Padol; 1984; 19(4):365-70. PubMed ID: 6504544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Composition, cross-linking and thermal stability of bone and skin collagens in patients with osteogenesis imperfecta.
    Herbage D; Borsali F; Buffevant C; Flandin F; Aguercif M
    Metab Bone Dis Relat Res; 1982; 4(2):95-101. PubMed ID: 6815415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Widespread disturbance in extracellular matrix collagen biomarker responses to teriparatide therapy in osteogenesis imperfecta.
    Nicol L; Srikanth P; Henriksen K; Sun S; Smith R; Karsdal MA; Nagamani SCS; Shapiro J; Lee B; Leder BZ; Orwoll E
    Bone; 2021 Jan; 142():115703. PubMed ID: 33099032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collagen crosslinks and mineral crystallinity in bone of patients with osteogenesis imperfecta.
    Vetter U; Weis MA; Mörike M; Eanes ED; Eyre DR
    J Bone Miner Res; 1993 Feb; 8(2):133-7. PubMed ID: 8442432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.
    Mörike M; Brenner RE; Bushart GB; Teller WM; Vetter U
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):73-7. PubMed ID: 1520286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The amino-acid composition of human hard tissue collagens in osteogenesis imperfecta and dentinogenesis imperfecta.
    Eastoe JE; Martens P; Thomas NR
    Calcif Tissue Res; 1973 May; 12(2):91-100. PubMed ID: 4710795
    [No Abstract]   [Full Text] [Related]  

  • 29. An unusual pattern of peptide-bound lysine metabolism in collagen from an infant with lethal perinatal osteogenesis imperfecta.
    Petrovic OM; Miller EJ
    J Clin Invest; 1984 Jun; 73(6):1569-75. PubMed ID: 6427276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    Biochem J; 1984 Jan; 217(1):103-15. PubMed ID: 6421277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type V osteogenesis imperfecta: a new form of brittle bone disease.
    Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
    J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glycosaminoglycan and collagen analyses in osteogenesis imperfecta].
    Bleckmann H; Kresse H; Wollensak J; Buddecke E
    Z Kinderheilkd; 1971; 110(1):74-84. PubMed ID: 4253437
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of cyanogen bromide peptides of type I collagen from a patient with lethal osteogenesis imperfecta.
    Kirsch E; Glanville RW; Krieg T; Müller P
    Biochem J; 1983 Jun; 211(3):599-603. PubMed ID: 6411063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteogenesis imperfecta: biochemical studies of bone collagen.
    Fujii K; Tanzer ML
    Clin Orthop Relat Res; 1977 May; (124):271-7. PubMed ID: 598086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical signs and diagnosis of osteogenesis imperfecta in three dogs.
    Campbell BG; Wootton JA; Krook L; DeMarco J; Minor RR
    J Am Vet Med Assoc; 1997 Jul; 211(2):183-7. PubMed ID: 9227748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COL1A2 and COL2A1 expression in temporal bone of lethal osteogenesis imperfecta.
    Khetarpal U; Morton CC
    Arch Otolaryngol Head Neck Surg; 1993 Dec; 119(12):1305-14. PubMed ID: 17431984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructural studies of bones from patients with osteogenesis imperfecta.
    Traub W; Arad T; Vetter U; Weiner S
    Matrix Biol; 1994 Aug; 14(4):337-45. PubMed ID: 7827757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphometric analysis of type I collagen fibrils in the osteoid of osteogenesis imperfecta.
    Sarathchandra P; Pope FM; Ali SY
    Calcif Tissue Int; 1999 Nov; 65(5):390-5. PubMed ID: 10541766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
    Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
    Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective collagen fibril formation and mineralization in osteogenesis imperfecta with congenital joint contractures (Bruck syndrome).
    Brenner RE; Vetter U; Stöss H; Müller PK; Teller WM
    Eur J Pediatr; 1993 Jun; 152(6):505-8. PubMed ID: 8335019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.